Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024
Compare Profit and Loss Results of Aarey Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
473.00
147.00
326.00
221.77%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
473.00
147.00
326.00
221.77%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
-4.00
-6.00
-150.00%
Raw Materials Consumed
472.00
102.00
370.00
362.75%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
0.00
7.00
-7.00
-100.00%
Operating Expenses
1.00
5.00
-4.00
-80.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
2.00
1.00
50.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
471.00
134.00
337.00
251.49%
Operating Profit (PBDIT) excl Other Income
2.00
13.00
-11.00
-84.62%
Other Income
9.00
0.00
9.00
0%
Operating Profit (PBDIT)
12.00
13.00
-1.00
-7.69%
Interest
4.00
3.00
1.00
33.33%
Profit before Depriciation and Tax
8.00
10.00
-2.00
-20.00%
Depreciation
1.00
4.00
-3.00
-75.00%
Profit Before Taxation & Exceptional Items
6.00
5.00
1.00
20.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
5.00
1.00
20.00%
Provision for Tax
2.00
1.00
1.00
100.00%
Profit After Tax
4.00
4.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
53.00
9.00
44.00
488.89%
Profit Available for appropriations
57.00
14.00
43.00
307.14%
Appropriations
57.00
14.00
43.00
307.14%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.42
4.49
-3.07
-68.37%
Profit And Loss - Net Sales
Net Sales 473.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024
Profit And Loss - Interest
Interest 4.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.02 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024
Footer loading
